drugset / Trial / NCT02254083
Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to assess the tolerability of an intravenous infusion of 0.5 and 1.0 mg (actual 0.8 mg) BIBT 986 BS per hour over 32 hours as well as pharmacokinetics and the effect on blood coagulation parameters
Timeline
- Start
- 2003-02
- Primary completion
- 2003-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIBT 986 BS | Unknown | 0.5 mg | Intravenous |
| Subject | BIBT 986 BS | Unknown | 0.8 mg | Intravenous |
Indications
No indication recorded.